根据合作意向书，双方就成立合资公司或其他合作架构进行探讨，以整合双方技术、制造与市场资源， 提升产品竞争力与市场渗透率。双方就人形机器人谐波减速器及相关零部件研发、设计、测试与制造流 程进行初步技术交流，并于可行性确认后，另行署签正式协议以明确知识产权、技术授权与成果归属事 宜。双方可于自愿基础上共享市场资讯与潜在客户名单，并探讨未来在市场推广、品牌合作或供应链协 同等方面可行性。双方依据市场与技术发展状况，逐步扩展合作领域，以建立具有长期策略意义的合作 关系。 由于各下游客户对不同的终端产品应用场景有不同的要求，其测试方式、测试条件、测试设备、标准要 求等可能会存在差异，单一客户的样品内部测试结果，并不能代表能满足下游其他客户的使用要求、测 试条件和标准。 金帝股份表示，本次签订的战略合作意向书有利于公司将自身在制造与研发领域的优势，与东培股份在 技术与产品应用方面的经验相结合，将公司研发优势转化为具有市场竞争力的终端产品，通过建立稳 定、高效的合作机制，提升公司在产品规划及整体运营上的效率。 公司将持续推进产品型号拓展研发测试，同时积极拓展产业链客户，为后续量产和市场拓展奠定了基 础，提升新质生产力。截至 ...

Group 1 - Daikin Heavy Industries' subsidiary signed a contract worth approximately 1.339 billion yuan for an offshore wind farm project in Europe, accounting for 35.41% of the company's audited revenue for 2024 [1] Group 2 - Zhaoyi Innovation announced that several board members and senior management plan to reduce their holdings by a total of 249,000 shares, due to personal financial needs, with the reduction period set from December 15, 2025, to March 14, 2026 [2] Group 3 - Jushi Chemical received a notice from the China Securities Regulatory Commission regarding an investigation for suspected violations of information disclosure laws, while the company's operations continue normally [3][6] Group 4 - Chaozhuo Aerospace announced a stock suspension due to major matters being planned by its controlling shareholders, which may lead to a change in control [4] Group 5 - Heng Rui Medicine received approval for clinical trials of SHR-1139 injection, a biopharmaceutical with no similar products approved for sale domestically or internationally, with a cumulative R&D investment of approximately 100.13 million yuan [5] Group 6 - Huayou Pharmaceutical's HYP-6589 tablet for treating advanced non-small cell lung cancer received a clinical trial application acceptance notice, with no similar products approved for sale [8] Group 7 - Renfu Pharmaceutical's application for the marketing license of Dexamethasone L-amphetamine capsules was accepted, aimed at treating ADHD, with a cumulative R&D investment of approximately 90 million yuan [10] Group 8 - Huibo Group won a bid for a 1.596 billion yuan project for the restoration of an oil field in Iraq [10]

格隆汇11月21日丨金帝股份(603270.SH)公布，公司与东培工业股份有限公司（简称"东培股份"）签署 了《战略合作意向书》，本着平等互利、优势互补、诚信合作、共同发展的原则，确认双方有意就人形 机器人谐波减速器总成及其关键零部件相关业务进行合作，结合公司在制造与研发领域的能力，以及东 培股份在技术与产品应用方面的经验，共同探讨建立合资或其他合作架构的可行性，并就市场、技术及 投资等事项展开沟通与评估，以推动双方长期稳定的合作发展。 ...

Regulatory Actions - Haosai is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure, but the company states that its operations remain normal and the investigation will not significantly impact management [2] - Central Plaza and its executives received a warning letter from the Jiangsu Securities Regulatory Bureau for failing to timely disclose significant litigation progress, which led to inaccurate financial reporting [3] - Guolian Aquatic received a warning letter from the Guangdong Securities Regulatory Bureau for non-operating fund occupation by its controlling shareholder, which was not disclosed in a timely manner [9] Corporate Actions - Jiarong Technology is planning a major asset restructuring and has suspended trading of its shares, expected to last no more than 10 trading days [4] - Maiwei Co. announced a debt restructuring totaling 371 million yuan, with an expected loss of 85.465 million yuan, aimed at improving cash flow and reducing receivables risk [5] - New World plans to use up to 850 million yuan of idle fundraising to purchase financial products or deposits, with a total of 575 million yuan already invested in such products [6] Legal Matters - Sunshine Nuohuo's lawsuit against Hengsheng Pharmaceutical has entered the second instance, with the original claim amounting to 20 million yuan and a counterclaim of 7.4073 million yuan [8] Product Development - Huyou Pharmaceutical's HYP-6589 tablet has received acceptance for clinical trial applications for treating advanced non-small cell lung cancer [7] - Renfu Pharmaceutical's application for the marketing license of a new ADHD treatment has been accepted, with no similar products currently available in the domestic market [10] Strategic Partnerships - Jindi Co. signed a strategic cooperation letter of intent with Dongpei Co. to explore collaboration on humanoid robot harmonic reducer assemblies and key components [11] Share Buybacks and Holdings - Yuyuan Co. has repurchased 1 million A-shares for a total of approximately 5.3864 million yuan as part of a buyback plan [12] - Yuheng Pharmaceutical's executives increased their holdings by 1.12%, acquiring a total of 25 million shares [13] Major Contracts - Huayou Huibo has been awarded a contract worth 225 million USD for the Iraq NaftKhana oilfield project, which is expected to significantly impact future earnings [16] - Dajin Heavy Industry's subsidiary signed a contract worth approximately 1.339 billion yuan for a European offshore wind farm project, representing 35.41% of the company's expected annual revenue [17]

证券代码：603270 证券简称：金帝股份 公告编号：2025-109 山东金帝精密机械科技股份有限公司 关于签订战略合作意向书的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 履约的重大风险及不确定性：本次签订的《战略合作意向书》系双方为 加强战略合作而订立的框架性协议，仅作为双方合作意愿和基本原则的框架性、 意向性的初步约定，不涉及具体金额，相关具体合作项目由双方根据业务发展需 求另行签订相关合作协议进行约定，敬请广大投资者注意投资风险。 对上市公司当年业绩的影响：本次相关协议的签署对公司业务和经营的 独立性不产生影响，不会对公司当年经营业绩产生重大影响。 特别风险提示：公司将根据合作事项进展情况，严格按照相关法律法规 和规范性文件的要求，及时履行信息披露义务，敬请投资者注意投资风险。 一、合作意向书签订的基本情况 近日，山东金帝精密机械科技股份有限公司（以下简称"公司"）与东培工 业股份有限公司（以下简称"东培股份"）签署了《战略合作意向书》，本着平等 互利、优势互补、诚信合作、共同发展的原则，确认 ...

人民财讯11月21日电，金帝股份（603270）11月21日公告，近日，公司与东培股份签署《战略合作意向 书》，确认双方有意就人形机器人谐波减速器总成及其关键零部件相关业务进行合作，共同探讨建立合 资或其他合作架构的可行性，并就市场、技术及投资等事项展开沟通与评估，以推动双方长期稳定的合 作发展。该意向书不涉及具体金额，任何一方均不因本意向书而负有投资、采购、授权、合资或其他履 约义务。 ...

Core Viewpoint - JinDi Co., Ltd. has signed a strategic cooperation letter of intent with DongPei Industrial Co., Ltd. to explore collaboration in humanoid robot harmonic reducer assemblies and key components [1] Group 1 - The cooperation aims to discuss the feasibility of establishing a joint venture or other collaborative framework [1] - The letter of intent does not specify any financial amounts, and specific cooperation projects will be detailed in separate agreements [1]

Group 1 - The company, Jindi Co., has signed a strategic cooperation intention letter with Dongpei Industrial Co., confirming their intent to collaborate on humanoid robot harmonic reducer assemblies and key components [1]

证券代码：603270 证券简称：金帝股份 公告编号：2025-108 山东金帝精密机械科技股份有限公司 关于对外担保进展的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 | | 被担保人名称 | | 山东博源精密机械有限公司 | | | --- | --- | --- | --- | --- | | | 本次担保金额 | 3,000.00 | 万元 | | | 担保对象 | 实际为其提供的担保余额 | 17,000.00 | 万元 | | | | 是否在前期预计额度内 | 是 □否 | | □不适用：_________ | | | 本次担保是否有反担保 | 是 ☑否 | | □不适用：_________ | 累计担保情况 | 对外担保逾期的累计金额（万元） | 0.00 | | --- | --- | | 截至本公告日上市公司及其控股 | 175,500.00 | | 子公司对外担保总额（万元） | | | 对外担保总额占上市公司最近一 期经审计净资产的比例（%） | 81.52 ...

证券代码：603270 证券简称：金帝股份 公告编号：2025-107 山东金帝精密机械科技股份有限公司 2025年第三次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一) 股东会召开的时间：2025 年 11 月 17 日 (二) 股东会召开的地点：山东省聊城市中华路与松桂大街交叉口创新高科 产业园 3 号楼会议室 审议结果：通过 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 137 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 157,789,208 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | 72.0147 | | 份总数的比例（%） | | (四) 表决方式是否符合《公司法》及《公司章程》的规定，股东会主持情 况等。 本次股东会由公司董事会负责召集，以现场投票与网络投票相结合的方式表 决，董事长郑广 ...